DaVita Inc. (DVA) Return on Invested Capital (ROIC): 10.58%
Is DaVita Inc.’s return on invested capital (ROIC) high or low?
DaVita Inc.'s return on invested capital (ROIC) of 10.58% is 14% above its 5-year average of 9.31%, near the high end of its 5-year range (7.13%–11.40%).
As of Monday, June 15, 2026. 3.73% below its 12-month average of 10.99%.
DVA Return on Invested Capital (ROIC) Chart
DVA Average Return on Invested Capital (ROIC) Chart
DVA Current vs Average Return on Invested Capital (ROIC) Chart
DVA Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
10.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
10.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
9.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
8.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
8.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
8.38%
CURRENT VS TTM AVG
-3.73%
CURRENT VS 3Y AVG
+11.57%
CURRENT VS 5Y AVG
+13.58%
CURRENT VS 10Y AVG
+25.60%
CURRENT VS 15Y AVG
+24.75%
CURRENT VS 20Y AVG
+26.32%
DVA Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DaVita Inc. (DVA) | $13.40B | 10.58% | 10.99% | 9.48% | 9.31% |
| The Cooper Companies, Inc. (COO)vs › | $13.24B | 3.98% | 4.09% | 3.90% | 4.29% |
| Solventum Corporation (SOLV)vs › | $13.66B | 17.76% | 12.30% | 11.68% | 9.71% |
| Align Technology, Inc. (ALGN)vs › | $12.52B | 9.94% | 9.96% | 10.13% | 11.66% |
| Baxter International Inc. (BAX)vs › | $10.77B | -1.79% | -0.86% | -2.61% | 0.30% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -24.28% | -15.13% | -6.38% | -2.73% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 7.35% | 8.59% | 9.78% | 13.56% |
| Charles River Laboratories International, Inc. (CRL)vs › | $9.03B | 8.36% | 4.65% | 6.09% | 6.66% |
| Tempus AI, Inc. (TEM)vs › | $8.35B | -10.29% | -59.01% | -58.33% | -53.58% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.73B | 2.04% | 2.21% | 2.35% | 2.39% |
Capital Efficiency
ROIC
10.6%
ROE
-114.7%
DaVita Inc. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
DaVita Inc. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for DaVita Inc. (DVA)?
- The return on invested capital (ROIC) for DVA stock is 10.58%.
- Is DaVita Inc.'s return on invested capital (ROIC) high or low?
- DaVita Inc.'s return on invested capital (ROIC) of 10.58% is 14% above its 5-year average of 9.31%, near the high end of its 5-year range (7.13%–11.40%).
- What is the TTM average return on invested capital (ROIC) for DaVita Inc. (DVA)?
- The TTM average return on invested capital (ROIC) for DVA stock is 10.99%.
- What is the 3Y average return on invested capital (ROIC) for DaVita Inc. (DVA)?
- The 3Y average return on invested capital (ROIC) for DVA stock is 9.48%.
- What is the 5Y average return on invested capital (ROIC) for DaVita Inc. (DVA)?
- The 5Y average return on invested capital (ROIC) for DVA stock is 9.31%.
- What is the 10Y average return on invested capital (ROIC) for DaVita Inc. (DVA)?
- The 10Y average return on invested capital (ROIC) for DVA stock is 8.42%.
- What is the 15Y average return on invested capital (ROIC) for DaVita Inc. (DVA)?
- The 15Y average return on invested capital (ROIC) for DVA stock is 8.48%.
- What is the 20Y average return on invested capital (ROIC) for DaVita Inc. (DVA)?
- The 20Y average return on invested capital (ROIC) for DVA stock is 8.38%.
DaVita Inc. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 10.58% |
| 2024-12-31 | 11.40% |
| 2023-12-31 | 8.82% |
| 2022-12-31 | 7.13% |
| 2021-12-31 | 9.38% |
| 2020-12-31 | 8.58% |
| 2019-12-31 | 8.17% |
| 2018-12-31 | 7.12% |
| 2017-12-31 | 8.66% |
| 2016-12-31 | 8.69% |
| 2015-12-31 | 4.13% |
| 2014-12-31 | 7.53% |
| 2013-12-31 | 6.87% |
| 2012-12-31 | 5.84% |
| 2011-12-31 | 9.54% |
| 2010-12-31 | 8.90% |
| 2009-12-31 | 9.00% |
| 2008-12-31 | 8.61% |
| 2007-12-31 | 8.92% |
| 2006-12-31 | 8.33% |
| 2005-12-31 | 5.44% |
| 2004-12-31 | 11.02% |
| 2003-12-31 | 13.44% |
| 2002-12-31 | 15.20% |
| 2001-12-31 | 12.81% |
| 2000-12-31 | 5.02% |
| 1999-12-31 | 15.96% |
| 1998-12-31 | 3.27% |
| 1997-12-31 | 5.91% |
| 1996-12-31 | 12.59% |
Related Metrics
About DaVita Inc.
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Javier J. Rodriguez